blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3126846

EP3126846 - BIOMARKERS AND METHODS FOR MEASURING AND MONITORING JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.08.2018
Database last updated on 20.05.2024
FormerRequest for examination was made
Status updated on  06.01.2017
FormerThe international publication has been made
Status updated on  02.11.2016
Most recent event   Tooltip17.08.2018Application deemed to be withdrawnpublished on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Crescendo Bioscience
341 Oyster Point Blvd.
South San Francisco, CA 94080 / US
[2017/14]
Former [2017/06]For all designated states
Crescendo Bioscience
341 Oyster Point Blvd.
South San Francisco, CA 94080 / US
For all designated states
Eastman, Scott
341 Oyster Point Blvd
South San Francisco, California 94080 / US
For all designated states
Sasso, Eric
341 Oyster Point Blvd
South San Francisco, California 94080 / US
Inventor(s)01 / EASTMAN, Scott
c/o Crescendo Bioscience
341 Oyster Point Blvd
South San Francisco, CA 94080 / US
02 / SASSO, Eric
c/o Crescendo Bioscience
341 Oyster Point Blvd
South San Francisco, CA 94080 / US
 [2017/14]
Former [2017/06]01 / EASTMAN, Scott
341 Oyster Point Blvd
South San Francisco, California 94080 / US
02 / SASSO, Eric
341 Oyster Point Blvd
South San Francisco, California 94080 / US
Representative(s)Gibson, Mark
Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[N/P]
Former [2017/06]Gibson, Mark
Sagittarius IP
Three Globeside
Fieldhouse Lane
Marlow, Buckinghamshire SL7 1HZ / GB
Application number, filing date15772723.130.03.2015
[2017/06]
WO2015US23302
Priority number, dateUS201461974390P02.04.2014         Original published format: US 201461974390 P
[2017/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015153437
Date:08.10.2015
Language:EN
[2015/40]
Type: A1 Application with search report 
No.:EP3126846
Date:08.02.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 08.10.2015 takes the place of the publication of the European patent application.
[2017/06]
Search report(s)International search report - published on:KR08.10.2015
(Supplementary) European search report - dispatched on:EP28.07.2017
ClassificationIPC:G01N33/564, C12Q1/68, G06F19/24
[2017/35]
CPC:
G01N33/564 (EP,US); C12Q1/6883 (EP,US); G09B7/00 (US);
G16B40/20 (EP,US); C12Q2600/118 (EP,US); C12Q2600/158 (EP,US);
G01N2800/102 (EP,US); G01N2800/56 (EP,US); G01N2800/60 (EP,US);
G16B40/00 (EP,US) (-)
Former IPC [2017/06]G01N33/68, C12Q1/68, G06F19/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/06]
TitleGerman:BIOMARKER UND VERFAHREN ZUR MESSUNG UND ÜBERWACHUNG DER AKTIVITÄT VON JUVENILER IDIOPATHISCHER ARTHRITIS[2017/06]
English:BIOMARKERS AND METHODS FOR MEASURING AND MONITORING JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY[2017/06]
French:BIOMARQUEURS ET PROCÉDÉS DE MESURE ET DE SURVEILLANCE DE L'ACTIVITÉ DE L'ARTHRITE IDIOPATHIQUE JUVÉNILE[2017/06]
Entry into regional phase28.10.2016National basic fee paid 
28.10.2016Search fee paid 
28.10.2016Designation fee(s) paid 
28.10.2016Examination fee paid 
Examination procedure28.10.2016Examination requested  [2017/06]
28.10.2016Date on which the examining division has become responsible
12.04.2017Amendment by applicant (claims and/or description)
27.02.2018Application deemed to be withdrawn, date of legal effect  [2018/38]
17.04.2018Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2018/38]
Fees paidRenewal fee
30.01.2017Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.03.201804   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]US2011137851  (CAVET GUY L [US], et al) [I] 1-11,13-15 * abstract, paragraphs [0004], [0009], [0014]-[0017], [0020], [0027]-[0031], [00.34], [0035], [0105], [0122], [0123], [0128], [0137]-[0139], [0151], [0245]-[0251], [0266]-[0272]. *;
 [X]  - SARAH RINGOLD ET AL, "A7: Initial Assessment of Multi-biomarker Disease Activity Assay in JIA", ARTHRITIS & RHEUMATOLOGY (HOBOKEN), US, (20140301), vol. 66, doi:10.1002/art.38418, ISSN 2326-5191, pages S10 - S11, XP055391055 [X] 1,3,4,15 * page S10 - page S11; figure 1 *

DOI:   http://dx.doi.org/10.1002/art.38418
 [X]  - S. RINGOLD ET AL, "FRI0556 A Multi-Biomarker Disease Activity Blood Test in Patients with Juvenile Idiopathic Arthritis", ANNALS OF THE RHEUMATIC DISEASES, GB, (201403), vol. 73, no. Suppl 2, doi:10.1136/annrheumdis-2014-eular.5846, ISSN 0003-4967, pages 587.3 - 588, XP055390643 [X] 1-15 * page S10 and S11, figure 1. *

DOI:   http://dx.doi.org/10.1136/annrheumdis-2014-eular.5846
 [Y]  - MICHAEL CENTOLA ET AL, "Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis", PLOS ONE, (20130409), vol. 8, no. 4, doi:10.1371/journal.pone.0060635, page e60635, XP055391198 [Y] 1-15 * the whole document, especially the abstract and figures 2 and 3. *

DOI:   http://dx.doi.org/10.1371/journal.pone.0060635
 [Y]  - ALESSANDRO CONSOLARO ET AL, "Development and validation of a composite disease activity score for juvenile idiopathic arthritis", ARTHRITIS & RHEUMATISM, US, (20090515), vol. 61, no. 5, doi:10.1002/art.24516, ISSN 0004-3591, pages 658 - 666, XP055391199 [Y] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1002/art.24516
International search[X]US2011137851  (CAVET GUY L [US], et al) [X] 1-28 * See abstract; paragraphs [0015], [0105]; claims 1-88. *;
 [A]US2013052665  (LING BRUCE XUEFENG [US], et al) [A] 1-28 * See abstract; claims 1-15. *;
 [A]WO2013167727  (UNIV MUENSTER WILHELMS [DE]) [A] 1-28 * See abstract; claims 1-24. *;
 [A]  - DUURLAND et al., "Current developments in the use of biomarkers for juvenile idiopathic arthritis", Current Rheumatology Reports, (20140121), vol. 16, no. 3, pages 1 - 6, XP055229218 [A] 1-28 * See the whole document. *

DOI:   http://dx.doi.org/10.1007/s11926-013-0406-3
 [A]  - PRAKKEN et al., "Juvenile idiopathic arthritis", The Lancet, (20110000), vol. 377, no. 9783, pages 2138 - 2149, XP055229222 [A] 1-28 * See the whole document. *

DOI:   http://dx.doi.org/10.1016/S0140-6736(11)60244-4
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.